Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032363 · ClinicalTrials.gov registry record · NA
Implementing Depression and Adherence Treatment
A NA study, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07032363: Recruiting NA study, sponsored by University of Miami.
NCT07032363 is a NA study that is actively recruiting participants, run by University of Miami. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07032363, a NA study, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are: What proportion of patients start an evidence-based treatment for depression (reach)? What percentage of patients show clinical improvement in depression and what percentage attain viral undetectability within one year (effectiveness)? Researchers will compare high and low reach clinics to further inform tailored implementation strategies for uptake and maintenance. Clinics will be randomized into one of two study arms: core versus enhanced strategies. In both arms, core strategies will be utilized. Enhanced clinics will also receive more resource-intensive training.
Primary Outcome
Proportion of patients who start an evidence-based treatment for depression out of patients identified with positive depression and a detectable viral load
Interventions
- OTHER Core Implementation Strategies
- OTHER Enhanced Implementation Strategies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-05-20 |
| Est. Completion | 2030-05 |
| Phase | NA |
What NCT07032363 shows while recruiting
NCT07032363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Core Implementation Strategies is the first listed.
NCT07032363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07032363 about?
NCT07032363 is a clinical study titled "Implementing Depression and Adherence Treatment". The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are: What proportion of patients start an evidence-based treatment fo...
What is the current status of trial NCT07032363?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-05-20. Estimated completion is 2030-05.
What interventions are being tested in trial NCT07032363?
The interventions under investigation include: Core Implementation Strategies (OTHER), Enhanced Implementation Strategies (OTHER).
Who is sponsoring clinical trial NCT07032363?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07032363's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI